5 December 2024
Latham & Watkins Advises Coherus BioSciences in US$558.4 Million Divesture of UDENYCA Franchise to Intas Pharmaceuticals
Advising firms
Deal team
28 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Josh Dubofsky Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Benjamin Potter Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Danny Nordstrom | Latham & Watkins LLP | Associate | corporate | Not stated |
| Avery Brust | Latham & Watkins LLP | Associate | corporate | Not stated |
| Rachelle Polsky | Latham & Watkins LLP | Associate | corporate | Not stated |
| Tim Plummer | Latham & Watkins LLP | Associate | corporate | Not stated |
| Drew Capurro | Latham & Watkins LLP | Partner | public company representation | Orange County |
| Kennedy Holmes | Latham & Watkins LLP | Associate | public company representation | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Gregory Conyers | Latham & Watkins LLP | Associate | tax | Not stated |
| Chris Hazuka | Latham & Watkins LLP | Partner | intellectual property | San Diego |
| Mizuna Sekine | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Chris Schott | Latham & Watkins LLP | Partner | healthcare regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA regulatory | Washington, D.C. |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy/HIPAA | Bay Area |
| Jay Metz | Latham & Watkins LLP | Partner | compensation and benefits | Bay Area |
| Greg Rodgers | Latham & Watkins LLP | Partner | debt finance | New York |
| Dan Van Fleet | Latham & Watkins LLP | Partner | debt finance | Bay Area |
| Rychelle Andersen | Latham & Watkins LLP | Associate | debt finance | Not stated |
| Joshua Holian | Latham & Watkins LLP | Partner | antitrust | Bay Area |
| Patrick English | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Hanna Nunez Tse | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Les Carnegie | Latham & Watkins LLP | Partner | CFIUS | Washington, D.C. |
| Catherine Hein | Latham & Watkins LLP | Counsel | CFIUS | Washington, D.C. |
| Asia Cadet | Latham & Watkins LLP | Associate | CFIUS | Not stated |
| Steve Feldman | Latham & Watkins LLP | Partner | litigation | New York |
25 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 558m (US$558.4 million)
- What the figure measures
- Total transaction value
- Client
- Coherus BioSciences, Inc.Sell-side
- Counterparties
- Intas Pharmaceuticals Ltd. (Buy-side)